Page 33 - Health News

Govt forms 5-member committee to review pharma marketing practices

It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days

Happilo: Farmer's son and a nutty biz selling good health in small packs

Vikas Nahar's enterprise does Rs 40 cr a month on average, selling exotic and local nuts processed at 16,000 sq ft of processing space that he now plans to scale up by another 100,000 sq ft

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

Peerless group poised for growth, targets Rs 1,000 crore turnover

PGFI's revenues for the year ended March 31, 2022, had stood at around Rs 498 crore while profit for the year was at 102.76 crore. But pre-Covid, turnover was in the region of Rs 535 crore

The SSI Mantra: India's own surgical robot boasts cheaper price tag

SSI Mantra has already been used for 22 complex procedures at Delhi hospital

Pashu Aadhaar: How will it help control lumpy skin disease in cattle

What is Pashu Aadhaar and how to apply for it? Here's all you need to know

Lupin gets nod for arthritis drug 'Rymti' from Canadian health authority

Drug maker Lupin on Tuesday said its biosimilar product Rymti, indicated for the treatment of arthritis, has received approval from the Canadian health authority. The company's product is the biosimilar of reference drug Enbrel (Etanercept). The product is indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis , plaque psoriasis and paediatric plaque psoriasis. "The approval for Rymti in Canada is a key milestone in our endeavours to improve access to medicines," Lupin Biotech President Cyrus Karkaria said in a statement. It underscores the scientific success of the company's biosimilar programmes and commitment to advancing healthcare through innovation, he added.

Tata Consumer enters health supplements biz with 'GoFit' range for women

Tata GoFit is available in two pack sizes of 500 grams and one kg, with 18 grams of protein per serving of 25 grams in two flavours--rich chocolate and cafe mocha

Serum Institute may give India its first adult tuberculosis vaccine

Will be critical to the success of India's drive to eliminate TB by 2025

What is Tomato Flu? Causes, symptoms, prevention, and treatment

Tomato Flu cases have surged in India, more than three months after its inception. Read this detailed article to understand Tomato Flu, its causes, symptoms, diagnosis and treatment

Pricing regulator closely watching prices of diabetes drug going off patent

Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations

Medicine purchases by inpatients exempt from GST: Tamil Nadu AAR

An outpatient will be charged GST for medicines and consumables bought that were prescribed in the course of providing health care services

Over 2.2 mn precautionary Covid jabs being administered per day: Health min

While the daily average Covid vaccination doses cross 2.8 million mark, over 880,000 special vaccination camps have been organised in the country

Laying eyewear optic fibre to make 400 mn specs per year: Lenskart's Bansal

As part of that strategy, the SoftBank-backed firm is setting up the world's largest eyewear manufacturing plant in Bhiwadi, a city in Rajasthan

Bayer brings kidney disease treatment drug to India at 1/15th US cost

Brand named Kerendia (finerenone) will cost Rs 97.5 per day as treatment cost in India

Study shows regular exercise may lower risk of Covid infection, severity

If you exercise regularly, then there are chances you may have a lower risk of Covid-19 infection and severity, including hospital admission and death, finds a new study

Covid pandemic-induced income blues not yet over for seven states/UTs

Residents of 6 states and a Union Territory are yet to recover from the Covid-19 pandemic-induced income shock, data compiled by the National Statistical Office for 21 states and UTs for FY22 shocks.

303 new Covid-19 cases reported in Thane; active tally stands at 1,641

Thane district in Maharashtra has reported 303 new coronavirus positive cases, taking its infection tally to 7,37,728, a health official said on Friday. With the addition of these cases on Thursday, the district currently has 1,641 active cases, he said. Since no patient died due to the infection during the day, the fatality count remained unchanged at 11,938, he said, adding that the overall recovery figure has reached 7,24,599, he added.

What is Langya virus and what are its symptoms: Here's the full detail

Langya virus has affected at least 35 people in Henan and Shandong provinces of China. What is its origin? What are its symptoms? How to protect yourself from it? Know everything in detail.

India working on indigenous kit to test monkeypox as cases on the rise

At present, 15 VRDLs are equipped to test for monkeypox, including the National Institute of Virology (NIV) in Pune